CIK 0001720893
- Non-accelerated filer
- Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821386754
- Phone
- +1 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- 4 Planned sale O'Neill Vincent sold 155 shares at $1.29 ($199)
- 4 Planned sale CEO and President sold 2,134 shares at $1.28 ($2,739)
- 4/A Insider Changes in Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO and President sold 1,427,494 shares at an average $1.61 ($405,135)
- 4 Planned sale O'Neill Vincent sold 165 shares at $2.62 ($432)
- 4 Planned sale CEO and President sold 5,268 shares at an average $2.62 ($13,823)
- 4 Planned sale Chief Financial Officer sold 1,069 shares at $2.64 ($2,817)
- 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,008 shares at $2.64 ($2,656)
- 4 Planned sale Rodriguez Javier sold 1,012 shares at $2.64 ($2,667)
- 4 Planned sale Chief Scientific Officer sold 1,067 shares at $2.64 ($2,812)
- 4 Exercise or conversion Chief Scientific Officer acquired 521 shares (option exercise)
- 4 Exercise or conversion CEO and President acquired 2,609 shares (option exercise)
- 4 Exercise or conversion Rodriguez Javier acquired 521 shares (option exercise)
- 4 Exercise or conversion Chief Financial Officer acquired 521 shares (option exercise)
- 4 Exercise or conversion Chief Medical Officer acquired 521 shares (option exercise)
Page 6 of 14 · 276 filings